NP49425 Generic and Biosimilar Transition Medicines

Overview

Lots (10)

• Cytokine Modulators (Golimumab, Tocilizumab, and Etanercept)

  Supply of generic cand biosimilar transition medicines to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per line to six (6) Framework Participants. Full details of Goods and volumes can be found within the ITT (Invitation to Tender) documents.

  £99,950,577Won by Brown and BurkWon by Lupin Healthcare UK LtdWon by Accord Healthcare LtdWon by Amarox LimitedWon by Amgen LtdWon by AOP Orphan LtdWon by Celix Pharma Ltd.Won by Celltrion Healthcare United Kingdom LimitedWon by Chiesi LtdWon by Dr Falk Pharma UK LtdWon by Ferring Pharmaceuticals LimitedWon by Fresenius KabiWon by Gedeon Richter UK LtdWon by Glenmark Pharmaceuticals Europe LtdWon by Janssen-Cilag LtdWon by Mercury Pharma GroupWon by MSN LabsWon by Perennial Pharma LtdWon by PfizerWon by Roche Products LtdWon by Samsung Bioepis LtdWon by SandozWon by SERB SAWon by Takeda UK LimitedWon by Teva UK LtdWon by Theramex HQ UK LtdWon by STADA UK - Thornton & RossWon by Viatris UK Healthcare LtdWon by Vifor Pharma UK LimitedWon by Zentiva Pharma UK LtdWon by Zydus Pharmaceuticals UK Ltd

• Psychiatry and Neurology Medicines

  Supply of psychiatry and neurology medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

  £60,787Won by Brown and BurkWon by Lupin Healthcare UK Ltd

• Cytokine Modulators (Omalizumab)

  Supply of cytokine modulators (omalizumab) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

  £15,643,757Won by Mercury Pharmaceuticals LimitedWon by Celltrion Healthcare United Kingdom Limited

• Gastrointestinal, Endocrine, Blood, and Multiple Sclerosis Medicines

  Supply of gastrointestinal, endocrine, blood, and multiple sclerosis medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

  £26,183,523Won by Mercury Pharmaceuticals LimitedWon by Accord Healthcare LtdWon by Amarox LimitedWon by AOP Orphan LtdWon by Biocon Pharma UK LtdWon by Celix Pharma Ltd.Won by Chiesi LimitedWon by Dr Falk Pharma UK LtdWon by Dr Reddy's Laboratories (UK) LtdWon by Ferring Pharmaceuticals LimitedWon by Glenmark Pharmaceuticals Europe LtdWon by MSN LabsWon by Perennial Pharma LtdWon by SERB SAWon by Takeda UK LimitedWon by Teva UK LtdWon by STADA UK - Thornton & RossWon by Viatris UK Healthcare LtdWon by Wockhardt UK LimitedWon by Zydus Pharmaceuticals UK Ltd

• Denosumab (Osteoporosis) and Ferric Carboxymaltose

  Supply of denosumab (osteoporosis) and ferric carboxymaltose to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

  £27,420,432Won by Celltrion Healthcare United Kingdom LimitedWon by Fresenius Kabi LtdWon by Accord Healthcare LtdWon by Dr Reddy's Laboratories (UK) LtdWon by Teva UK LtdWon by STADA UK - Thornton & RossWon by Zentiva UKWon by Gedeon Richter UK LtdWon by Samsung Bioepis LtdWon by SandozWon by Vifor Pharma UK Limited

• Apremilast

  Supply of apremilast to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

  £1,495,958Won by Accord Healthcare LtdWon by Celix Pharma Ltd.Won by Teva UK LtdWon by STADA UK - Thornton & Ross

• Cardiovascular and Respiratory Medicines

  Supply of cardiovascular and respiratory medicines to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

  £457,484Won by Brown and BurkWon by Celix Pharma Ltd.Won by Teva UK LtdWon by STADA UK - Thornton & RossWon by Zentiva UKWon by Zydus Pharmaceuticals UK LtdWon by CST Pharma Ltd

• Nintedanib

  Supply of nintedanib to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

  £27,322,496Won by Celix Pharma Ltd.Won by Dr Reddy's Laboratories (UK) LtdWon by Teva UK LtdWon by Wockhardt UK LimitedWon by Accord Healthcare LtdWon by Mercury Pharmaceuticals Limited

• Cancer Medicines (Group 1)

  Supply of cancer medicines (group 1) to NHS Scotland. The Authority has awarded this Lot as a ranked multi supplier Framework Agreement per product line.

  £15,175,245Won by Accord Healthcare LtdWon by Ferring Pharmaceuticals LimitedWon by Glenmark Pharmaceuticals Europe LtdWon by Teva UK LtdWon by STADA UK - Thornton & RossWon by Zentiva UKWon by Pfizer

• Cancer Medicines (Group 2)

  Supply of cancer medicines (group 2) to NHS Scotland. The Authority has awarded this Lot as an unranked multi supplier Framework Agreement per product line.

  £21,258,752Won by Mercury Pharmaceuticals LimitedWon by Celltrion Healthcare United Kingdom LimitedWon by Fresenius Kabi LtdWon by Accord Healthcare LtdWon by Dr Reddy's Laboratories (UK) LtdWon by STADA UK - Thornton & RossWon by Zentiva UKWon by Gedeon Richter UK LtdWon by Samsung Bioepis LtdWon by SandozWon by Amgen Ltd

Award outcome

Awarded value

£101,668,208

Award date

18 December 2025

Contract period

1 February 2026 → 30 September 2028

Contract ending soon? Skim tracks incumbents and flags recompetes early. Start for Free to set up alerts.

How to win this tender

Skim reads the notice and every document attached to it, scores the fit against your company profile for a clear bid or no-bid call, then drafts each answer from your own evidence and past bids. You review, refine and submit — on time, with every requirement covered.

See exactly how Skim’s agents do this →

Comparing platforms? Skim is set against the alternatives for pre-tender intelligence, tender management software and bid management software.